Compass Therapeutics, Inc. CMPX
Set alert
0.79 USD +0.03 +4.01%
At close · Oct 30
0.80 +0.01 +1.72%
After hours · Oct 30, 6:40 PM ET
0.7408 Day range 0.7969
0.747 52-week range 6.69
- YTD
- -85.35%
- 1 year
- -78.86%
- Open
- 0.756
- Prev close
- 0.7562
- Mkt cap
- 141.64M
- Vol
- 2.92M
- Avg vol
- 4.27M
- EPS
- -0.39
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.7408
- High
- 0.7969
- Forward P/E
- -10.86
- Beta
- 1.30
- Short ratio
- 12.39
- Inst. own
- 88.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 5.68
- 200-d avg
- 4.58
- 1y target
- 13.64
Financial health
Altman Z-Score
-0.21 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 3
Valuation
P/E -12.8×
FY 2018 5y median -4.7× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 4.3×
FY 2018 5y median 1.6× FY 2025
P/FCF -17.2×
FY 2018 5y median -9.4× FY 2025
EV/EBITDA -12.7×
FY 2018 5y median -4.3× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -5.8%
FY 2018 5y median -10.7% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -33.8%
FY 2018 5y median -33.8% FY 2025
ROIC -35.3%
FY 2018 5y median -35.3% FY 2025
ROA -30.3%
FY 2018 5y median -30.3% FY 2025
Growth (YoY)
Revenue -100.0%
FY 2018 FY 2025
Operating Income -28.6%
FY 2018 FY 2025
EPS (diluted) -16.7%
FY 2018 FY 2025
Free Cash Flow -9.5%
FY 2018 FY 2025
Financial Health
Current Ratio 15.0×
FY 2018 5y median 15.0× FY 2025
Quick Ratio 15.0×
FY 2018 5y median 15.0× FY 2025
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 0.3×
FY 2018 5y median 0.8× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31